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1. Introduction 
Amino acid sequence determinations of immuno- 
globulin chains have given considerable insight into 
the genetics of antibody diversity (for review, see ref. 
[l] ). Primary sequence studies on rabbit immuno- 
globulin chains are facilitated by the use of hyper- 
immunization of rabbits with bacterial vaccines to 
elicit the production of high concentrations of mole- 
cularly uniform antibodies [2]. The majority (approxi- 
mately 90%) of the rabbit immunoglobulin light chain 
pool is of the K-type, having an unblocked N-terminus; 
considerable sequence data on these unblocked chains 
have been derived from structural studies of homo- 
geneous antibodies [3,4] . However, several K-chains 
having blocked N-termini have recently been reported 
[5,6] ; little structural data are available on these 
blocked chains. 
In this report, the amino-terminal sequences of six 
such homogeneous blocked k-chains are presented. 
These sequences are homologous to unblocked K-chains, 
indicating that the blocked chains are derived from 
the major unblocked population by post-translational 
processing and are not encoded by different genes. 
2. Materials and methods 
2.1. Enzymes 
Pronase was purchased from Sigma Chemical Co., 
St. Louis, MO., and carboxypeptidase A from 
Worthington Biochemical Co., Freehold, NJ. 
2.2. Blocked K-chains 
Light chains 3322-D [6] and 3392 were a gift of 
North-Holland Publishing Company - Amsterdam 
Drs L. E. Cannon and M. N. Margolies. Other light 
chains were isolated [7] in this laboratory following 
partial reduction and alkylation of homogeneous anti- 
bodies elicited by hyperimmunization of rabbits with 
streptococcal vaccines [2] . These k-chains were 
classified as having blocked N-termini by the absence 
of detectable levels of phenylthiohydantoin-amino 
acids upon automated sequence analysis [5,6]. 
2.3. Pronase digestion of light-chains 
The blocked K-chains (2.5 mg) were completely 
reduced in 7 M guanidine-HCl, 0.5 M Tris-HCl, 
pH 8.2 (10 mg/ml) using 5 mM dithioerythritol for 
2 h, and alkylated with 10.5 mM iodoacetamide for 
30 mm, all at room temperature. Excess reagents 
were removed by dialysis against 0.1 M NH40H and 
the proteins lyophilized. 
Pronase digestion (enzyme to substrate ratio, 1:25, 
w/w) was carried out in 1% NHaHCOs buffer, pH 8.2 
(5 mg/ml) for 3 h at 37”C, followed by lyophiliza- 
tion to terminate the digestion and remove the buffer. 
The digest was then applied to a column (1.3 X 1.5 cm, 
2 ml) of Amberlite IR-120 (H’-form), which had been 
exhaustively washed with water. Peptides containing 
no free amino group were purified from the unretarded 
fraction by paper electrophoresis [8] . 
2.4. C’yanogen bromide cleavage of 3664 K-chain 
The K-chain (10 mg) was cleaved with 50 mg CNBr 
in 0.5 ml 70% (v/v) formic acid for 24 h at 4°C. The 
mixture was then applied directly to a column 
(1.2 X 30 cm) of Sephadex G-25 medium in 50% 
(v/v) formic acid, and the blocked N-terminal peptide 
was purified by paper electrophoresis from the includ- 
ed fractions. 
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2.5. Analytical methods 3. Results and discussion 
Amino acid analysis was performed using a Durrum 
D-500 analyzer following hydrolysis in constant boiling 
HCl, in vacua, for 72 h (3664 peptides) or 22 h at 
110°C. The dried hydrolysates of peptides containing 
homoserine were dissolved in 0.5 ml pyridine-acetate 
buffer, pH 6.5, and heated at 100°C for 1 h before 
analysis [9] . 
More than 80% of each blocked light chain prepa- 
ration was bound by insolubilized antisera specific 
for the b-locus (K chain constant region) allotypes 
(table 1). This established that the blocked chains 
were of the K- rather than h-type. 
High voltage paper electrophoresis was carried out 
using the apparatus and buffers described previously 
[lo] . The N-terminal peptides, having no free amino 
group, were identified as such by their positive reac- 
tion with the hypochlorite-starch-iodide reagent [ 1 l] 
and their lack of reaction with ninhydrin. The mobi- 
lity of all peptides was measured relative to pyrrolid- 
2-one&carboxylic acid (-1 .O) and e-Dnp-lysine (0). 
Digestion with carboxypeptidase A (0.5 pg enzyme/ 
mnol peptide) was carried out in 0.5% NH4HCOs 
buffer, pH 8.4, (0.2 nmol/pl) at 37°C for periods from 
0.5-24 h; the amino acid(s) released was identified on 
the Durrum D-500 analyzer. 
2.6. Quantitation of b-locus markers on K-chains 
Quantitative determination of b-allotypes was carried 
out using insolubilized anti-b-allotype ant&era in a 
radioimmunoassay as described previously [ 121. 
Following pronase digestion, a single blocked 
peptide was isolated in good yield from each K-chain 
(table l), indicating that the chains were homogeneous 
in their N-terminal region, although the lower yield 
from some chains (e.g. 3392) might reflect the 
presence of a minor undetected variant. The pronase 
peptides were characterized from their amino acid 
composition and their mobility on paper electropho- 
resis [ 131. In addition, the tripeptide from 3664 was 
digested with carboxypeptidase A, which released 
valine 0.9 mol/mol peptide after 0.5 h. Each blocked 
pronase peptide contained glutamic acid on analysis 
and pyrrolid-2-one-5-carboxylic acid was assumed to 
be the N-terminal amino acid in each case. The pro- 
posed structure of these peptides is presented in 
table 1; the peptide blu-Val was isolated from five 
of the six chains studied. 
The N-terminal sequence of two K-chains (4035 
and 3664) was investigated further. Pronase digestion 
Table 1 
N-Terminal pronase peptides of blocked K-chains 
K-Chain 
designation 
Vaccine used to 
elicit antibodya 
K-Chain 
allotype 
Isolated blocked pronase peptides 
Amino acid compositionb Mobility YieldC Proposed 
sequence 
pH 6.5 pH 3.5 
3664 Strep C 
3660 Strep A 
4035 Strep C 
4295-7 Strep C 
3322-D Pneu VIII 
3392 Pneu III 
b4 
b4 
b4 
b5 
b5 
b4 
GlU l.,,,Val,.OOJleO.,, 
Glu ,.iO,Val,.OO 
Ghl ,.,,,Val,.,, 
Glu I.I~,Val,.O, 
Glu l.ls,Val,.OO 
Glu 1.18,Val,.00 
-0.51 -0.35 0.65 %lu-Be-Val 
-0.69 -0.55 0.60 %lu-Val 
-0.66 -0.55 0.55 ci;lu-Val 
-0.67 0.68 %lu-Val 
-0.67 0.59 CirGlu-Val 
-0.66 0.47 Qlu-Val 
aStrep C, Strep A, Pneu VIII, Pneu III designate the streptococcal Group C, Group A, pneumococcal type VIII, type III vaccines, 
respectively 
bAmino acid compositons were determined following 72 h hydrolysis of the 3664 peptide and 22 h hydrolysis of all other peptides 
CYields are expressed as mol peptide/mol a-chain after ion-exchange chromatography 
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of 4035 under less harsh conditions (enzyme to 
substrate ratio of 1:70, by weight, for 3 h at 37°C) 
released %lu-Val in lower yield than above, and a 
second blocked peptide (composition: Glui.26, Thri.20, 
Val iec, I.eu,s,) was isolated in a yield of 0.22 mol/ 
mol of ~-chain. The mobility of this second peptide at 
pH 6.5 (-0.45) indicated a charge of -1 for a tetra- 
peptide; the C-terminal sequence was determined as 
-Leu-Thr by digestion with carboxypeptidase A. The 
structure l&u-Val-Leu-Thr- is therefore proposed 
for the N-terminus of 4035. 
Only one light chain of the six (3664) contained 
methionine (0.89 mol/mol ~-chain) upon analysis. 
By homology with unblocked K-chains, the methionine 
residue was assumed to be near the N-terminus, and 
cleavage with CNBr released an N-terminal peptide with 
the composition: Glui,~, Vall.oo, Ileo.s2, Hsee.ss. 
The peptide was recovered in low yield (0.13 mol/ 
mol K-chain after gel filtration), presumably because 
of the resistance of the -Met-Thr- sequence in light 
chains to CNBr cleavage [ 141. The mobility of this 
peptide at pH 6.5 (-0.40) indicated a charge of -1 for 
a tetrapeptide; digestion with carboxypeptidase A 
allowed the C-terminal sequence to be determined as 
-Val-Hse. The proposed structure of this peptide is 
%lu-Ile-Val-Hse. 
Two different N-terminal sequences were therefore 
found for the blocked K-chains (fig.1); both of these 
differ from the sequence of blocked h-chains [ 151. 
The variation in sequence did not correlate with the 
constant region allotype, the vaccine used to elicit 
Sequence Group 1 
Unblocked 
Blocked 
Sequence Group 2 
Unblocked 
Blocked 
the antibody (table 1) or the pedigree of the rabbit 
producing the light chain (rabbits 4035 and 3664 
had the same parents, and rabbits 3322 and 3392 
belonged to a different colony from the others). 
The blocked sequences are homologous to two 
common sequences of unblocked K-chain (fig.1). 
The -Ile-Val- sequence (residues 2 and 3) in blocked 
chains correlates with the presence of methionine at 
position 4, as found in unblocked chains [4] . Internal 
glutamine or glutamic acid residues are present in some 
unblocked molecules [4] at position 1 of the sequence 
group 1 and position 2 of the sequence group (see 
fig.l). It is proposed that the pyrrolid-2-one-5-carboxy- 
lit acid residue of blocked K-chains arises during post- 
translational processing of the precursor molecule, 
by non-enzymatic cyclization of an N-terminal 
glutamine residue, as suggested for mouse X-chain 
[ 161. The blocked K-chains are therefore derived from 
the same source as unblocked K-chains, and are 
probably not encoded by different genes. 
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Ala-Asp- Ile-Val-Met-Thr-G lx-Thr- 
r Glu-Val-Leu-Thr- 
Fig.1. N-Terminal sequences of blocked and unblocked K-chains. Blocked ~-chains 3664 and 4035 are compared with two 
common sequences of unblocked K-chains (from ref. [4] ). The numbering systep is from ref. 141. 
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